Scrip Deals

Scrip Deals

Current Articles

• Europe’s Biotech Edge Lies In Science-First Investing
  2026-04-02 07:40 UTC by Lucie Ellis-Taitt
• Insilico’s CEO On AI, Drug Novelty And Beating China Biotech At R&D
  2026-04-01 15:33 UTC
• BioBytes: AI-Related Deals In Q1 ‘26
  2026-04-01 08:14 UTC by Sushmita Panda
• Factors Driving Change For Medtechs And Biotechs – A Legal View
  2026-04-01 07:28 UTC by Ashley Yeo
• M&A: South Korean Firms Shift To Factories Before Pipelines
  2026-03-30 08:43 UTC by Mainbayar Badarch
• BioBytes: AI-Related Deals In Q4 ‘24
  2026-03-30 07:04 UTC by David Wild
• Daiichi Sankyo Looks To Deploy ‘Smarter’ R&D Approach To ADCs
  2026-03-25 16:32 UTC by Jessica Merrill
• Could CAR-T Cells Cure Some Autoimmune Diseases?
  2026-03-25 07:57 UTC by Melanie Senior
• The Commercial Test: Psychedelics Move From Fringe Science To Doctor’s Office
  2026-03-25 07:56 UTC by Manas Mishra
• Oncology’s Next Decade: The Therapies And Players Reshaping A $400bn Future
  2026-03-23 21:09 UTC by Edwin Elmhirst|Lucie Ellis-Taitt
• Practicalities For AI-Enabled Devices As Digital (R)evolution Picks Up Pace
  2026-03-23 08:35 UTC by Ashley Yeo
• Chugai’s Narrow Partnering Strategy Means Less Competition
  2026-03-23 08:33 UTC by Mandy Jackson
• Execs On The Move: February 2026
  2026-03-18 11:06 UTC by In Vivo Team
• Adapt To Survive: Private Hospitals In A High-Pressure Landscape
  2026-03-18 11:05 UTC by Ashley Yeo
• An Irregular Regulatory Agency: Industry Contends With An Unpredictable FDA
  2026-03-18 10:56 UTC by Alaric DeArment
• Astellas Bets On Degradation Over Inhibition In Race To Crack KRAS G12D
  2026-03-16 16:47 UTC by David Wild
• The Autonomous Lab: Part 2
  2026-03-16 14:03 UTC by David Wild
• Deals In Depth: February 2026
  2026-03-16 13:54 UTC by Maureen Riordan|Deanna Kamienski
• Podcast: Onchilles Pharma’s Neutrophil-Derived Path To Pan-Cancer Therapy
  2026-03-12 06:47 UTC by David Wild
• At The Immune Frontier, The Hardest Questions Are Commercial
  2026-03-11 21:24 UTC by David Wild

Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative.